Human epidermal growth factor receptor-2 (HER2) is a diagnostic and prognostic factor for breast cancer, and HER2-positive breast cancer is one of the several subtypes of breast cancer, which accounts for about 15% of early-stage breast cancers [7]. Here, ERBB2 is linked to breast carcinoma.